Mobile

A single center open-label uncontrolled study to investigate the prostate specific antigen (PSA) and tumor vascularization response rate of neoadjuvant therapy with BAY 43-9006 single agent therapy in...

Update Il y a 4 ans
Reference: ISRCTN62522358

A single center open-label uncontrolled study to investigate the prostate specific antigen (PSA) and tumor vascularization response rate of neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable prostate cancer

Extract

Not provided at time of registration

Inclusion criteria

  • Prostate cancer

Links